Verona pharma to present successful tqt analysis demonstrating no clinically relevant effect on cardiac conduction at the american thoracic society 2022

Abstract supports ongoing phase 3 program and planned nda submission abstract supports ongoing phase 3 program and planned nda submission

VRNA Ratings Summary

VRNA Quant Ranking